EA031449B1 - Бактериальный штамм-акцептор, экспрессирующий рекомбинантный dsbc - Google Patents

Бактериальный штамм-акцептор, экспрессирующий рекомбинантный dsbc Download PDF

Info

Publication number
EA031449B1
EA031449B1 EA201490274A EA201490274A EA031449B1 EA 031449 B1 EA031449 B1 EA 031449B1 EA 201490274 A EA201490274 A EA 201490274A EA 201490274 A EA201490274 A EA 201490274A EA 031449 B1 EA031449 B1 EA 031449B1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibody
seq
protein
dsbc
sequence
Prior art date
Application number
EA201490274A
Other languages
English (en)
Russian (ru)
Other versions
EA201490274A1 (ru
Inventor
Марк Эллис
Дэвид Пол Хамфриз
Original Assignee
Юсб Фарма, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юсб Фарма, С.А. filed Critical Юсб Фарма, С.А.
Publication of EA201490274A1 publication Critical patent/EA201490274A1/ru
Publication of EA031449B1 publication Critical patent/EA031449B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EA201490274A 2011-07-13 2012-07-13 Бактериальный штамм-акцептор, экспрессирующий рекомбинантный dsbc EA031449B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11173880 2011-07-13
PCT/EP2012/002945 WO2013007388A1 (en) 2011-07-13 2012-07-13 Bacterial host strain expressing recombinant dsbc

Publications (2)

Publication Number Publication Date
EA201490274A1 EA201490274A1 (ru) 2014-05-30
EA031449B1 true EA031449B1 (ru) 2019-01-31

Family

ID=46545736

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490274A EA031449B1 (ru) 2011-07-13 2012-07-13 Бактериальный штамм-акцептор, экспрессирующий рекомбинантный dsbc

Country Status (27)

Country Link
US (2) US9725516B2 (forum.php)
EP (2) EP2731973B1 (forum.php)
JP (3) JP6431370B2 (forum.php)
KR (1) KR102023786B1 (forum.php)
CN (1) CN103649124B (forum.php)
AU (1) AU2012283388B2 (forum.php)
BR (1) BR112013032871B1 (forum.php)
CA (1) CA2841824C (forum.php)
CY (1) CY1119985T1 (forum.php)
DK (1) DK2731973T3 (forum.php)
EA (1) EA031449B1 (forum.php)
ES (1) ES2659155T3 (forum.php)
HR (1) HRP20180226T1 (forum.php)
HU (1) HUE035674T2 (forum.php)
IL (1) IL229947B (forum.php)
IN (1) IN2014DN00202A (forum.php)
LT (1) LT2731973T (forum.php)
ME (1) ME02957B (forum.php)
MX (1) MX348738B (forum.php)
NO (1) NO2731973T3 (forum.php)
PL (1) PL2731973T3 (forum.php)
PT (1) PT2731973T (forum.php)
RS (1) RS56926B1 (forum.php)
SG (1) SG10201807560XA (forum.php)
SI (1) SI2731973T1 (forum.php)
SM (1) SMT201800068T1 (forum.php)
WO (1) WO2013007388A1 (forum.php)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ580245A (en) * 2007-03-22 2012-01-12 Biogen Idec Inc Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
EP2993231B1 (en) 2009-09-24 2018-08-01 UCB Biopharma SPRL Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
NO2731973T3 (forum.php) * 2011-07-13 2018-04-14
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
GB201223276D0 (en) * 2012-12-21 2013-02-06 Ucb Pharma Sa Antibodies and methods of producing same
MX390701B (es) 2014-12-22 2025-03-21 Ucb Biopharma Sprl Manufactura de proteína.
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
RU2018128784A (ru) 2016-01-27 2020-02-27 МЕДИММЬЮН, ЭлЭлСи Способы получения антител с заданным профилем гликозилирования
WO2019193418A1 (en) 2018-04-05 2019-10-10 Bio-Rad Abd Serotec Gmbh Display systems for proteins of interest
EP3877407A1 (en) * 2018-11-05 2021-09-15 F. Hoffmann-La Roche AG Methods of producing two chain proteins in prokaryotic host cells
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
US11674164B2 (en) 2019-03-18 2023-06-13 Bio-Rad Abd Serotec Gmbh Periplasmic fusion proteins
PL4010500T3 (pl) * 2019-08-05 2025-06-23 Wacker Chemie Ag Szczep bakteryjny do uwalniania białka rekombinowanego w sposobie fermentacji

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061090A2 (en) * 2000-12-14 2002-08-08 Genentech, Inc. Prokaryotically produced antibodies and uses thereof
US20060204493A1 (en) * 2004-09-02 2006-09-14 Genentech, Inc. Heteromultimeric molecules
WO2008118356A2 (en) * 2007-03-22 2008-10-02 Biogen Idec Ma Inc. Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
WO2011086141A1 (en) * 2010-01-14 2011-07-21 Ucb Pharma S.A. Bacterial host strain expressing recombinant dsbc

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8907617D0 (en) 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
US5474771A (en) 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
JPH08500963A (ja) 1992-04-28 1996-02-06 ザ・リージェンツ・オブ・ザ・ユニヴァーシティー・オブ・ミシガン ヒューマンｃｒａｂｐ−▲ｉ▼及びｃｒａｂｐ−▲ｉｉ▼
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP2000083670A (ja) 1998-09-09 2000-03-28 Hsp Kenkyusho:Kk ＤｓｂＡ／ＤｓｂＢ／ＤｓｂＣ／ＤｓｂＤ発現プラスミド
US6306619B1 (en) 1999-06-29 2001-10-23 Washington University DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
WO2002018446A2 (en) 2000-09-01 2002-03-07 Biogen, Inc. Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
CZ304484B6 (cs) 2000-12-14 2014-05-21 Genentech, Inc. Bakteriální hostitelské kmeny a způsob tvorby polypeptidu
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
MXPA04001566A (es) 2001-08-27 2004-05-17 Genentech Inc Un sistema para expresion y ensamblado de anticuerpos.
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
WO2003048306A2 (en) 2001-11-16 2003-06-12 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
GB0129105D0 (en) * 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
SI1517921T1 (sl) 2002-06-28 2006-10-31 Domantis Ltd Dvojno-specificni ligandi z zvisano serumsko razpolovno dobo
US7608429B2 (en) 2002-10-31 2009-10-27 Genentech, Inc. Methods and compositions for increasing antibody production
EP1570267B1 (en) 2002-12-03 2011-10-12 UCB Pharma, S.A. Assay for identifying antibody producing cells
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
ATE482235T1 (de) 2003-06-13 2010-10-15 Biogen Idec Inc Aglycosyl-anti-cd154 (cd40-ligand) antikörper und deren verwendungen
EP2221317A3 (en) 2003-06-30 2011-07-27 Domantis Limited PEGylated single domain antibodies (dAb)
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
AU2004261198A1 (en) 2003-07-26 2005-02-10 Biogen Idec Ma Inc. Altered antibodies having improved antigen-binding affinity
JP5102028B2 (ja) 2004-07-26 2012-12-19 バイオジェン・アイデック・エムエイ・インコーポレイテッド 抗ｃｄ１５４抗体
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
EP2535349A1 (en) 2007-09-26 2012-12-19 UCB Pharma S.A. Dual specificity antibody fusions
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
EP2993231B1 (en) 2009-09-24 2018-08-01 UCB Biopharma SPRL Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
CA2780143A1 (en) * 2009-11-05 2011-05-12 Genentech, Inc. Methods and composition for secretion of heterologous polypeptides
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
NO2731973T3 (forum.php) 2011-07-13 2018-04-14
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061090A2 (en) * 2000-12-14 2002-08-08 Genentech, Inc. Prokaryotically produced antibodies and uses thereof
US20060204493A1 (en) * 2004-09-02 2006-09-14 Genentech, Inc. Heteromultimeric molecules
WO2008118356A2 (en) * 2007-03-22 2008-10-02 Biogen Idec Ma Inc. Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
WO2011086141A1 (en) * 2010-01-14 2011-07-21 Ucb Pharma S.A. Bacterial host strain expressing recombinant dsbc

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HARA H, ET AL.: "OVERPRODUCTION OF PENICILLIN-BINDING PROTEIN 7 SUPPRESSES THERMOSENSITIVE GROWTH DEFECT AT LOW OSMOLARITY DUE TO AN SPR MUATION OF ESCHERICHIA COLI", MICROBIAL DRUG RESISTANCE., LIEBERT., US, vol. 02, no. 01, 1 January 1996 (1996-01-01), US, pages 63 - 72, XP008015427, ISSN: 1076-6294 *
HU, X. O'HARA, L. WHITE, S. MAGNER, E. KANE, M. GERARD WALL, J.: "Optimisation of production of a domoic acid-binding scFv antibody fragment in Escherichia coli using molecular chaperones and functional immobilisation on a mesoporous silicate support", PROTEIN EXPRESSION AND PURIFICATION., ACADEMIC PRESS, SAN DIEGO, CA., vol. 52, no. 1, 8 January 2007 (2007-01-08), SAN DIEGO, CA., pages 194 - 201, XP005758623, ISSN: 1046-5928, DOI: 10.1016/j.pep.2006.08.009 *
JAMES M. ARAMINI, PAOLO ROSSI, YUANPENG J. HUANG, LI ZHAO, MEI JIANG, MELISSA MAGLAQUI, RONG XIAO, JESSICA LOCKE, RAJESH NAIR, BUR: "Solution NMR structure of the NlpC/P60 domain of lipoprotein Spr from Escherichia coli: Structural evidence for a novel cysteine peptidase catalytic triad", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 47, no. 37, 1 September 2008 (2008-09-01), US, pages 9715 - 9717, XP002630320, ISSN: 0006-2960, DOI: 10.1021/bi8010779 *
MASKOS, K. ; HUBER-WUNDERLICH, M. ; GLOCKSHUBER, R.: "DsbA and DsbC-catalyzed Oxidative Folding of Proteins with Complex Disulfide Bridge Patterns In Vitro and In Vivo", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 325, no. 3, 17 January 2003 (2003-01-17), United Kingdom, pages 495 - 513, XP027180830, ISSN: 0022-2836, DOI: 10.1016/S0022-2836(02)01248-2 *

Also Published As

Publication number Publication date
JP2014521313A (ja) 2014-08-28
JP2018019719A (ja) 2018-02-08
LT2731973T (lt) 2018-02-26
CN103649124B (zh) 2016-04-13
MX348738B (es) 2017-06-27
JP2020028299A (ja) 2020-02-27
CA2841824C (en) 2021-07-13
AU2012283388B2 (en) 2017-04-20
ES2659155T3 (es) 2018-03-14
SI2731973T1 (en) 2018-04-30
US9725516B2 (en) 2017-08-08
RS56926B1 (sr) 2018-05-31
EP3339325A1 (en) 2018-06-27
US9957328B2 (en) 2018-05-01
AU2012283388A1 (en) 2014-01-09
DK2731973T3 (da) 2018-01-29
EA201490274A1 (ru) 2014-05-30
SG10201807560XA (en) 2018-10-30
PL2731973T3 (pl) 2018-04-30
PT2731973T (pt) 2018-02-22
ME02957B (me) 2018-07-20
BR112013032871A8 (pt) 2022-08-23
MX2014000302A (es) 2014-02-17
HUE035674T2 (en) 2018-05-28
BR112013032871A2 (pt) 2017-01-24
EP2731973B1 (en) 2017-11-15
CN103649124A (zh) 2014-03-19
US20170335003A1 (en) 2017-11-23
CY1119985T1 (el) 2018-12-12
IL229947B (en) 2019-10-31
WO2013007388A1 (en) 2013-01-17
JP6431370B2 (ja) 2018-11-28
KR102023786B1 (ko) 2019-09-20
SMT201800068T1 (it) 2018-03-08
EP2731973A1 (en) 2014-05-21
BR112013032871B1 (pt) 2022-09-27
US20140141468A1 (en) 2014-05-22
HRP20180226T1 (hr) 2018-03-09
JP7062626B2 (ja) 2022-05-17
KR20140039240A (ko) 2014-04-01
IN2014DN00202A (forum.php) 2015-06-05
CA2841824A1 (en) 2013-01-17
HK1194393A1 (zh) 2014-10-17
NO2731973T3 (forum.php) 2018-04-14

Similar Documents

Publication Publication Date Title
JP7062626B2 (ja) 組換えＤｓｂＣを発現する細菌宿主系統
US9493559B2 (en) Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity
US8969039B2 (en) Bacterial host strain comprising a mutant SPR gene and having reduced TSP activity
AU2017200545B2 (en) Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene
KR102036399B1 (ko) 단백질 발현용 재조합 박테리아 숙주 세포
JP6132551B2 (ja) シャペロン活性を保持するプロテアーゼ欠損ＤｅｇＰ並びにノックアウトＴｓｐ及びｐｔｒ遺伝子を持つ、組換えタンパク質発現のための細菌株
HK1194393B (en) Bacterial host strain expressing recombinant dsbc
BR112012016808B1 (pt) Cepa hospedeira bacteriana expressando dsbc recombinante e tendo atividade tsp reduzida

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM